Abstract: A method for providing keyword recommendations for a virtual keyboard includes, in responsive to determining a user is interacting with a virtual keyboard, identifying one or more devices associated with text inputted as written content into a text field in a user interface. The method includes identifying one or more portions of the written content relating to data generated by the one or more devices. The method includes identifying one or more portions of the data generated. In response to converting the one or more portions of the data generated to text, the method includes displaying the text for the one or more portions of the data generated by the one or more devices. In response to receiving a text selection with the text, the method includes displaying the text selection with the written content in the text field in the user interface.

Abstract: A method for providing keyword recommendations for a virtual keyboard includes, in responsive to determining a user is interacting with a virtual keyboard, identifying one or more devices associated with text inputted as written content into a text field in a user interface. The method includes identifying one or more portions of the written content relating to data generated by the one or more devices. The method includes identifying one or more portions of the data generated. In response to converting the one or more portions of the data generated to text, the method includes displaying the text for the one or more portions of the data generated by the one or more devices. In response to receiving a text selection with the text, the method includes displaying the text selection with the written content in the text field in the user interface.

Abstract: Computer technology for making sure that no viewer in an audience of multiple co-viewers will effectively be presented with audiovisual content portions that inappropriate and/or irrelevant for that co-viewer. Avoiding the effective presentation of inappropriate and/or irrelevant content to one or more of the co-viewers may involve currently conventional techniques such as blurring, scrambling, obscuring, distracting, etc.

Abstract: Disclosed is a heating element for use with an apparatus for heating aerosolizable material to volatilize at least one component of the aerosolizable material. The heating element includes a body and at least one retainer. The body is for forming a chamber for receiving the aerosolizable material. The at least one retainer is for restraining movement of the heating element relative to the apparatus when the heating element is installed in the apparatus.

Abstract: The present invention relates to a hydroxyalkyl starch conjugate and a method for preparing the same, said hydroxyalkyl starch conjugate comprising a hydroxyalkyl starch derivative and a cytotoxic agent, the cytotoxic agent comprising at least one secondary hydroxyl group, wherein the hydroxyalkyl starch is linked via said secondary hydroxyl group to the cytotoxic agent. The conjugate according to the present invention has a structure according to the following formula HAS?(-L-M)n wherein M is a residue of the cytotoxic agent, L is a linking moiety, HAS? is the residue of the hydroxyalkyl starch derivative, and n is greater than or equal to 1, and wherein the hydroxyalkyl starch derivative has a mean molecular weight (MW) above the renal threshold.

Abstract: The present invention relates to a hydroxyalkyl starch conjugate and a method for preparing the same, said hydroxy-yalkyl starch conjugate comprising a hydroxyalkyl starch derivative and a cytotoxic agent, the cytotoxic agent comprising at least one secondary hydroxyl group, wherein the hydroxyalkyl starch is linked via said secondary hydroxyl group to the cytotoxic agent. The conjugate according to the present invention has a structure according to the following formula HAS?(-L-M)n wherein M is a residue of the cytotoxic agent, L is a linking moiety, HAS? is the residue of the hydroxyalkyl starch derivative, and n is greater than or equal to 1, and wherein the hydroxyalkyl starch derivative has a mean molecular weight (MW) above the renal threshold.

Abstract: The present invention relates to a hydroxyalkyl starch conjugate and a method for preparing the same, said hydroxyalkyl starch conjugate comprising a hydroxyalkyl starch derivative and a cytotoxic agent, the cytotoxic agent comprising at least one secondary hydroxyl group, wherein the hydroxyalkyl starch is linked via said secondary hydroxyl group to the cytotoxic agent. The conjugate according to the present invention has a structure according to the following formula HAS?(-L-M)n wherein M is a residue of the cytotoxic agent, L is a linking moiety, HAS? is the residue of the hydroxyalkyl starch derivative, and n is greater than or equal to 1, and wherein the hydroxyalkyl starch derivative has a mean molecular weight (MW) above the renal threshold.

Abstract: The present invention relates to a hydroxyalkyl starch conjugate and a method for preparing the same, said hydroxy-yalkyl starch conjugate comprising a hydroxyalkyl starch derivative and a cytotoxic agent, the cytotoxic agent comprising at least one secondary hydroxyl group, wherein the hydroxyalkyl starch is linked via said secondary hydroxyl group to the cytotoxic agent. The conjugate according to the present invention has a structure according to the following formula HAS?(-L-M)n wherein M is a residue of the cytotoxic agent, L is a linking moiety, HAS? is the residue of the hydroxyalkyl starch derivative, and n is greater than or equal to 1, and wherein the hydroxyalkyl starch derivative has a mean molecular weight (MW) above the renal threshold.

Abstract: The present invention relates to a hydroxyalkyl starch conjugate and a method for preparing the same, said hydroxyalkyl starch conjugate comprising a hydroxyalkyl starch derivative and a cytotoxic agent, the cytotoxic agent comprising at least one secondary hydroxyl group, wherein the hydroxyalkyl starch is linked via said secondary hydroxyl group to the cytotoxic agent. The conjugate according to the present invention has a structure according to the following formula HAS?(-L-M)n wherein M is a residue of the cytotoxic agent, L is a linking moiety, HAS? is the residue of the hydroxyalkyl starch derivative, and n is greater than or equal to 1, and wherein the hydroxyalkyl starch derivative has a mean molecular weight (MW) above the renal threshold.